Hier werden die Unterschiede zwischen zwei Versionen angezeigt.
Nächste Überarbeitung Beide Seiten der Revision | |||
echinacea_angustifolia_dc [2015/11/03 15:48] andreas angelegt |
echinacea_angustifolia_dc [2015/11/04 10:33] andreas |
||
---|---|---|---|
Zeile 1: | Zeile 1: | ||
Echinacea angustifolia DC. - syn. Echinacea pallida var. angustifolia (DC.) Cronq.; Brauneria angustifolia (DC.) A.Heller - Asteraceae \\ | Echinacea angustifolia DC. - syn. Echinacea pallida var. angustifolia (DC.) Cronq.; Brauneria angustifolia (DC.) A.Heller - Asteraceae \\ | ||
- | narrow | + | narrow-leaf coneflower, purple cone flower, black sampson, **Schmalblättriger Sonnenhut**, |
Central North America, cultivated in USA, Switzerland, | Central North America, cultivated in USA, Switzerland, | ||
+ | |||
+ | A polysaccharidic fraction (EPF) obtained from Echinacea angustifolia roots inhibited carrageenan-induced paw oedema. "... furthermore, | ||
+ | [Anti‐inflammatory activity of a polysaccharidic fraction of Echinacea angustifolia., | ||
+ | |||
+ | The roots contain unsaturated alkylamides like undeca-2Z-en-8, | ||
+ | [Alkamides from the roots of Echinacea angustifolia., | ||
+ | |||
+ | Extracts of the roots are taken orally to support the therapy of colds and influenza. \\ | ||
+ | [Medicinal Plants of the World. Ben-Erik Van Wyk and Michael Wink, Pretoria 2004, 129] | ||
+ | |||
+ | "It is generally thought that no single constituent or group of constituents is responsible for the activities of echinacea. Rather, several groups of constituents (the alkamides, caffeic acid derivatives, | ||
+ | oral administration in man, alkamides are bioavailable, | ||
+ | [Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties., | ||
+ | |||
+ | {{: | ||
+ | Curtis’s Botanical Magazine, vol.87 [ser.3, vol.17], t.5281 (1861) [W.H.Fitch] \\ | ||
+ | [[http:// |